Showing results (321-330 of 389) with videos related to
Sort By:
Pageof 39
Cancer|February 2, 2016
Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trialMasayuki Takeda, Takeharu Yamanaka, Takashi Seto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2018
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung CancerThanyanan Reungwetwattana, Kazuhiko Nakagawa, Byoung Chul Cho, et al.Scientific Reports|May 30, 2025
Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort studyHiroaki Ogata, Kazuya Tsubouchi, Tomotsugu Takano, et al.Lung Cancer (Amsterdam, Netherlands)|April 20, 2025
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for advanced nonsquamous non-small cell lung cancer with impaired renal function: A multicenter, single-arm phase 2 trial (RESTART, LOGiK 2002)Yoshimasa Shiraishi, Takayuki Shimose, Kazunori Tobino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2019
Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: COMPASS (WJOG5610L)Takashi Seto, Koichi Azuma, Takeharu Yamanaka, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2021
Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLCYasuto Yoneshima, Satoshi Morita, Masahiko Ando, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group studyIsamu Okamoto, Hiroshige Yoshioka, Satoshi Morita, et al.Clinical Lung Cancer|September 16, 2022
Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal ImpairmentYasuto Yoneshima, Satoshi Morita, Masahiko Ando, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small-cell lung cancer: results of a west Japan thoracic oncology group trial (WJTOG0203)Koji Takeda, Toyoaki Hida, Tosiya Sato, et al.JTO Clinical and Research Reports|May 8, 2025
Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019LHideyuki Harada, Akito Hata, Masahiro Konno, et al.Pageof 39